Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd.

14
Strong Sell
  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000000W4
HKD
2.97
0.05 (1.71%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-141.00
36.00
133.00
177.00
262.00
201.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
249.00
-124.00
-135.00
-62.00
-39.00
-111.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
157.00
-16.00
78.00
192.00
324.00
121.00
Cash Flow from Investing Activities
-17.00
-25.00
-50.00
-112.00
-428.00
-56.00
Cash Flow from Financing Activities
-41.00
-109.00
-131.00
13.00
-121.00
857.00
Net Cash Inflow / Outflow
98.00
-151.00
-103.00
93.00
-226.00
921.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Profit Before Tax
-141.807787113459
434.566795180133
-575.00
-132.63%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
249.854682715241
691.961521214651
-442.00
-63.89%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
157.778963052668
1877.57335151288
-1,720.00
-91.60%
Cash Flow from Investing Activities
-17.6667859329215
-1012.89184872432
995.00
98.26%
Cash Flow from Financing Activities
-41.1100979774539
-1140.54692603368
1,099.00
96.40%
Net Cash Inflow / Outflow
98.4681205678568
-253.044974576106
351.00
138.91%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-0.53395857443506
22.8204486690208
-22.00
-102.34%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is 1,085.23% vs -120.41% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
157.78
-16.01
1,085.23%